The cell line development market is driven by rising biologics production, increasing demand for monoclonal antibodies, and advancements in expression systems, with North America leading and ...

Traditional approaches to biologics production—relying on one-size-fits-all expression vectors and empirical process optimization—have led to inefficiencies in expression, scalability, and ...

The key for optimizing cell-line development for antibody derivatives might just be to prioritize early assessment of product ...

The integrated approach is designed to adapt to the evolving needs of new therapeutic modalities, delivering both speed and performance.

New offering provides drug developers with flexible and powerful cell line development options for monoclonal antibodies, multi-specific and complex molecules SEATTLE--(BUSINESS WIRE)-- As drug ...

OneCyte, a leader in high-throughput single-cell analysis and cell line development technologies, and Kemp Proteins, a ...

Sartorius launched CellCelector CLD, an automated platform combining imaging and cell isolation to accelerate monoclonal cell ...

New GMP-grade cell lines with outstanding growth profile outperform industry standards and enable rapid growth performance for cell and gene therapies COLLEGE STATION, Texas--(BUSINESS WIRE)--Matica ...

Discover how to streamline your cell line development process for recombinant protein and monoclonal antibody production with this in-depth eBook. Whether you're working with CHO, HEK293, or hybridoma ...

SHANGHAI, Aug. 11, 2025 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced the launch of WuXia293 Stable ...